SEDI Insider filing browser
Filter by Company
×
Filter by $CAD Amount
×
Filter by Filing Type
Filter by Insider
×
 
Date Issuer Insider Transaction Amount New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
Filed 2024-05-03 09:53
Tx date 2024-05-02
$PHRX
Pharmadrug Inc.
Goldman, Zalman
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options

+500,000 vol
500,000
Filed 2024-05-03 09:52
Tx date 2024-05-02
$PHRX
Pharmadrug Inc.
Goldman, Zalman
4 - Director of Issuer
Direct Ownership
Options
00 - Opening Balance-Initial SEDI Report
Filed 2024-01-11 14:00
Tx date 2024-01-11
$PHRX
Pharmadrug Inc.
Li, Ka Yin Keith
5 - Senior Officer of Issuer
Direct Ownership
Options
52 - Expiration of options

-500,000 vol
0
Filed 2024-01-11 13:57
Tx date 2024-01-11
$PHRX
Pharmadrug Inc.
Li, Ka Yin Keith
5 - Senior Officer of Issuer
Direct Ownership
Options
52 - Expiration of options

+500,000 vol
500,000
Filed 2024-01-11 13:57
Tx date 2024-01-11
$PHRX
Pharmadrug Inc.
Li, Ka Yin Keith
5 - Senior Officer of Issuer
Direct Ownership
Options
52 - Expiration of options

+500,000 vol
Filed 2024-01-11 11:11
Tx date 2020-08-25
$PHRX
Pharmadrug Inc.
Li, Ka Yin Keith
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options
$-12,500
-250,000 vol
$0.05 each
-250,000
Filed 2020-08-31 11:06
Tx date 2020-08-25
$PHRX
Pharmadrug Inc.
Li, Ka Yin Keith
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options
$12,500
+250,000 vol
$0.05 each
Filed 2023-12-18 16:25
Tx date 2023-11-07
$PHRX
Pharmadrug Inc.
Appleby, Kyle Michael
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options

+500,000 vol
500,000
Filed 2023-12-18 16:13
Tx date 2023-10-20
$PHRX
Pharmadrug Inc.
Appleby, Kyle Michael
5 - Senior Officer of Issuer
Direct Ownership
Options
00 - Opening Balance-Initial SEDI Report
Filed 2023-12-18 09:08
Tx date 2023-11-07
$PHRX
Pharmadrug Inc.
McClory, Paul Gerard Joseph
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options

+750,000 vol
924,286
Filed 2023-12-18 09:05
Tx date 2023-11-07
$PHRX
Pharmadrug Inc.
Vassev, Nikolai
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options

+500,000 vol
642,857
Filed 2023-12-18 09:00
Tx date 2023-11-07
$PHRX
Pharmadrug Inc.
Kideckel, David
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options

+1,000,000 vol
1,107,143
Filed 2023-12-18 08:56
Tx date 2023-11-07
$PHRX
Pharmadrug Inc.
Steen, Robert
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options

+3,000,000 vol
3,000,000
Filed 2023-10-24 13:52
Tx date 2023-10-24
$PHRX
Pharmadrug Inc.
McClory, Paul Gerard Joseph
4 - Director of Issuer
Direct Ownership
Options
37 - Stock split or consolidation

-428,572 vol
174,286
Filed 2023-10-24 13:39
Tx date 2022-11-01
$PHRX
Pharmadrug Inc.
Fiederer, Jeremy
5 - Senior Officer of Issuer
Holder: Pink Cloud Management LLP (Indirect Ownership)
Options
52 - Expiration of options

-750,000 vol
0
Filed 2023-10-24 13:37
Tx date 2022-11-01
$PHRX
Pharmadrug Inc.
Fiederer, Jeremy
5 - Senior Officer of Issuer
Holder: Harry Resin (Indirect Ownership)
Options
52 - Expiration of options

-2,000,000 vol
0
Filed 2023-10-24 13:34
Tx date 2023-10-24
$PHRX
Pharmadrug Inc.
Fiederer, Jeremy
5 - Senior Officer of Issuer
Holder: Pink Cloud Management LLP (Indirect Ownership)
Options
37 - Stock split or consolidation

-642,857 vol
Filed 2023-10-24 13:34
Tx date 2023-10-24
$PHRX
Pharmadrug Inc.
Fiederer, Jeremy
5 - Senior Officer of Issuer
Holder: Harry Resin (Indirect Ownership)
Options
37 - Stock split or consolidation

-1,714,286 vol
Filed 2023-10-24 13:34
Tx date 2023-10-24
$PHRX
Pharmadrug Inc.
Fiederer, Jeremy
5 - Senior Officer of Issuer
Holder: Pink Could Management LLC (Indirect Ownership)
Common Shares
37 - Stock split or consolidation

-857,143 vol
Filed 2023-10-24 13:28
Tx date 2023-07-23
$PHRX
Pharmadrug Inc.
Van Slyke, Paul
5 - Senior Officer of Issuer
Direct Ownership
Options
52 - Expiration of options

-2,000,000 vol
0
Filed 2023-10-24 13:25
Tx date 2023-10-24
$PHRX
Pharmadrug Inc.
Van Slyke, Paul
5 - Senior Officer of Issuer
Direct Ownership
Options
37 - Stock split or consolidation

-1,714,286 vol
Filed 2023-10-24 13:18
Tx date 2022-04-13
$PHRX
Pharmadrug Inc.
Schwartz, Robert
4 - Director of Issuer
Direct Ownership
Options
52 - Expiration of options

-500,000 vol
0
Filed 2023-10-24 13:16
Tx date 2022-04-13
$PHRX
Pharmadrug Inc.
Schwartz, Robert
4 - Director of Issuer
Direct Ownership
Options
52 - Expiration of options

-220,000 vol
500,000
Filed 2023-10-24 13:16
Tx date 2022-04-13
$PHRX
Pharmadrug Inc.
Schwartz, Robert
4 - Director of Issuer
Direct Ownership
Options
52 - Expiration of options

-200,000 vol
Filed 2023-10-24 13:15
Tx date 2022-04-13
$PHRX
Pharmadrug Inc.
Schwartz, Robert
4 - Director of Issuer
Direct Ownership
Options
52 - Expiration of options

-500,000 vol
720,000
Filed 2023-10-24 13:13
Tx date 2022-04-13
$PHRX
Pharmadrug Inc.
Schwartz, Robert
4 - Director of Issuer
Direct Ownership
Options
52 - Expiration of options

-200,000 vol
Filed 2023-10-24 13:11
Tx date 2023-10-24
$PHRX
Pharmadrug Inc.
Schwartz, Robert
4 - Director of Issuer
Direct Ownership
Options
37 - Stock split or consolidation

-428,572 vol
Filed 2023-10-24 13:11
Tx date 2023-10-24
$PHRX
Pharmadrug Inc.
Schwartz, Robert
4 - Director of Issuer
Direct Ownership
Options
37 - Stock split or consolidation

-428,571 vol
Filed 2023-10-24 13:09
Tx date 2023-10-24
$PHRX
Pharmadrug Inc.
Schwartz, Robert
4 - Director of Issuer
Direct Ownership
Options
37 - Stock split or consolidation

-188,571 vol
Filed 2023-10-24 12:05
Tx date 2023-10-24
$PHRX
Pharmadrug Inc.
Schwartz, Robert
4 - Director of Issuer
Direct Ownership
Options
37 - Stock split or consolidation

-428,572 vol
Filed 2023-10-24 12:05
Tx date 2023-10-24
$PHRX
Pharmadrug Inc.
Schwartz, Robert
4 - Director of Issuer
Direct Ownership
Options
37 - Stock split or consolidation

-428,572 vol
174,286
Filed 2023-10-24 12:04
Tx date 2023-10-24
$PHRX
Pharmadrug Inc.
Vassev, Nikolai
4 - Director of Issuer
Direct Ownership
Options
37 - Stock split or consolidation

-428,572 vol
142,857
Filed 2023-10-24 11:56
Tx date 2023-10-24
$PHRX
Pharmadrug Inc.
Vassev, Nikolai
4 - Director of Issuer
Direct Ownership
Options
37 - Stock split or consolidation

-428,571 vol
Filed 2023-10-24 11:56
Tx date 2023-10-24
$PHRX
Pharmadrug Inc.
Vassev, Nikolai
4 - Director of Issuer
Direct Ownership
Options
37 - Stock split or consolidation

-428,571 vol
142,858
Filed 2023-10-24 11:55
Tx date 2023-10-24
$PHRX
Pharmadrug Inc.
Vassev, Nikolai
4 - Director of Issuer
Direct Ownership
Options
37 - Stock split or consolidation

-428,571 vol
571,429
Filed 2023-10-24 11:53
Tx date 2023-10-24
$PHRX
Pharmadrug Inc.
Van Slyke, Paul
5 - Senior Officer of Issuer
Direct Ownership
Options
37 - Stock split or consolidation

-1,714,286 vol
285,714
Filed 2023-10-24 11:53
Tx date 2023-10-24
$PHRX
Pharmadrug Inc.
Van Slyke, Paul
5 - Senior Officer of Issuer
Direct Ownership
Options
37 - Stock split or consolidation

-1,714,286 vol
Filed 2023-10-24 11:50
Tx date 2023-10-24
$PHRX
Pharmadrug Inc.
Schwartz, Robert
4 - Director of Issuer
Direct Ownership
Options
37 - Stock split or consolidation

-428,571 vol
Filed 2023-10-24 11:50
Tx date 2023-10-24
$PHRX
Pharmadrug Inc.
Schwartz, Robert
4 - Director of Issuer
Direct Ownership
Options
37 - Stock split or consolidation

-428,571 vol
174,287
Filed 2023-10-24 11:50
Tx date 2023-10-24
$PHRX
Pharmadrug Inc.
Schwartz, Robert
4 - Director of Issuer
Direct Ownership
Options
37 - Stock split or consolidation

-428,571 vol
Filed 2023-10-24 11:47
Tx date 2023-10-24
$PHRX
Pharmadrug Inc.
Schwartz, Robert
4 - Director of Issuer
Direct Ownership
Options
37 - Stock split or consolidation

-428,571 vol
Filed 2023-10-24 11:47
Tx date 2023-10-24
$PHRX
Pharmadrug Inc.
Schwartz, Robert
4 - Director of Issuer
Direct Ownership
Options
37 - Stock split or consolidation

-428,571 vol
602,858
Filed 2023-10-24 11:46
Tx date 2023-10-24
$PHRX
Pharmadrug Inc.
Schwartz, Robert
4 - Director of Issuer
Direct Ownership
Options
37 - Stock split or consolidation

-188,571 vol
1,031,429
Filed 2023-10-24 11:46
Tx date 2023-10-24
$PHRX
Pharmadrug Inc.
Schwartz, Robert
4 - Director of Issuer
Direct Ownership
Options
37 - Stock split or consolidation

-188,571 vol
Filed 2023-10-24 11:42
Tx date 2023-10-24
$PHRX
Pharmadrug Inc.
Quong, Al
4 - Director of Issuer
Direct Ownership
Options
37 - Stock split or consolidation

-428,571 vol
178,572
Filed 2023-10-24 11:41
Tx date 2023-10-24
$PHRX
Pharmadrug Inc.
Quong, Al
4 - Director of Issuer
Direct Ownership
Options
37 - Stock split or consolidation

-642,857 vol
607,143
Filed 2023-10-24 11:38
Tx date 2023-10-24
$PHRX
Pharmadrug Inc.
High Fusion Inc. (formerly Nutritional High International Inc.)
3 - 10% Security Holder of Issuer
Direct Ownership
Warrants
37 - Stock split or consolidation

-171,429 vol
28,571
Filed 2023-10-24 11:36
Tx date 2023-10-24
$PHRX
Pharmadrug Inc.
High Fusion Inc. (formerly Nutritional High International Inc.)
3 - 10% Security Holder of Issuer
Direct Ownership
Common Shares
37 - Stock split or consolidation

-7,674,099 vol
1,279,016
Filed 2023-10-24 11:32
Tx date 2023-10-24
$PHRX
Pharmadrug Inc.
McClory, Paul Gerard Joseph
4 - Director of Issuer
Direct Ownership
Options
37 - Stock split or consolidation

-428,571 vol
174,287
Filed 2023-10-24 11:32
Tx date 2023-10-24
$PHRX
Pharmadrug Inc.
McClory, Paul Gerard Joseph
4 - Director of Issuer
Direct Ownership
Options
37 - Stock split or consolidation

-428,571 vol
Filed 2023-10-24 11:31
Tx date 2023-10-24
$PHRX
Pharmadrug Inc.
McClory, Paul Gerard Joseph
4 - Director of Issuer
Direct Ownership
Options
37 - Stock split or consolidation

-428,571 vol
602,858
Filed 2023-10-24 11:29
Tx date 2023-10-24
$PHRX
Pharmadrug Inc.
McClory, Paul Gerard Joseph
4 - Director of Issuer
Direct Ownership
Options
37 - Stock split or consolidation

-188,571 vol
1,031,429
Filed 2023-10-24 11:26
Tx date 2023-10-24
$PHRX
Pharmadrug Inc.
McClory, Paul Gerard Joseph
4 - Director of Issuer
Holder: Cayland Trust (Indirect Ownership)
Common Shares
37 - Stock split or consolidation

-257,143 vol
42,857
Filed 2023-10-24 11:24
Tx date 2023-10-24
$PHRX
Pharmadrug Inc.
Kideckel, David
4 - Director of Issuer
Direct Ownership
Options
37 - Stock split or consolidation

-642,857 vol
107,143
Filed 2023-10-24 11:14
Tx date 2023-10-24
$PHRX
Pharmadrug Inc.
Frazier, Vernon Jim
4 - Director of Issuer
Direct Ownership
Options
37 - Stock split or consolidation

-188,571 vol
31,429
Filed 2023-10-24 11:02
Tx date 2023-10-24
$PHRX
Pharmadrug Inc.
Fiederer, Jeremy
5 - Senior Officer of Issuer
Holder: Pink Cloud Management LLP (Indirect Ownership)
Options
37 - Stock split or consolidation

-642,857 vol
Filed 2023-10-24 11:02
Tx date 2023-10-24
$PHRX
Pharmadrug Inc.
Fiederer, Jeremy
5 - Senior Officer of Issuer
Holder: Pink Cloud Management LLP (Indirect Ownership)
Options
37 - Stock split or consolidation

-642,857 vol
107,143
Filed 2023-10-24 10:59
Tx date 2023-10-24
$PHRX
Pharmadrug Inc.
Fiederer, Jeremy
5 - Senior Officer of Issuer
Holder: Harry Resin (Indirect Ownership)
Options
37 - Stock split or consolidation

-1,714,286 vol
Filed 2023-10-24 10:55
Tx date 2023-10-24
$PHRX
Pharmadrug Inc.
Fiederer, Jeremy
5 - Senior Officer of Issuer
Holder: Pink Could Management LLC (Indirect Ownership)
Common Shares
37 - Stock split or consolidation

-857,143 vol
Filed 2023-10-24 10:55
Tx date 2023-10-24
$PHRX
Pharmadrug Inc.
Fiederer, Jeremy
5 - Senior Officer of Issuer
Holder: Pink Could Management LLC (Indirect Ownership)
Common Shares
37 - Stock split or consolidation

-857,143 vol
142,857
Filed 2023-09-07 09:53
Tx date 2023-09-06
$PHRX
Pharmadrug Inc.
Steen, Robert
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Options
00 - Opening Balance-Initial SEDI Report
Filed 2023-09-07 09:53
Tx date 2023-09-06
$PHRX
Pharmadrug Inc.
Steen, Robert
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
00 - Opening Balance-Initial SEDI Report
Filed 2022-08-04 15:29
Tx date 2021-02-27
$PHRX
Pharmadrug Inc.
Cohen, Daniel
5 - Senior Officer of Issuer
Direct Ownership
Warrants
55 - Expiration of warrants

-250,000 vol
1,348,022
Filed 2022-08-04 15:28
Tx date 2021-01-10
$PHRX
Pharmadrug Inc.
Cohen, Daniel
5 - Senior Officer of Issuer
Direct Ownership
Warrants
55 - Expiration of warrants

-225,000 vol
1,598,022
Filed 2022-08-04 15:26
Tx date 2020-08-16
$PHRX
Pharmadrug Inc.
Cohen, Daniel
5 - Senior Officer of Issuer
Direct Ownership
Warrants
55 - Expiration of warrants

-200,000 vol
475,000
Filed 2022-08-03 18:54
Tx date 2022-08-02
$PHRX
Pharmadrug Inc.
Cohen, Daniel
5 - Senior Officer of Issuer
Holder: Daniel Cohen - RESP (Indirect Ownership)
Common Shares
16 - Acquisition or disposition under a prospectus exemption
$9,794
+195,893 vol
$0.05 each
195,893
Filed 2022-08-03 18:53
Tx date 2018-08-16
$PHRX
Pharmadrug Inc.
Cohen, Daniel
5 - Senior Officer of Issuer
Holder: Daniel Cohen - RESP (Indirect Ownership)
Common Shares
00 - Opening Balance-Initial SEDI Report
Filed 2022-08-03 18:52
Tx date 2022-08-02
$PHRX
Pharmadrug Inc.
Cohen, Daniel
5 - Senior Officer of Issuer
Holder: Daniel Cohen - RRSP (Indirect Ownership)
Common Shares
16 - Acquisition or disposition under a prospectus exemption
$18,190
+363,801 vol
$0.05 each
363,801
Filed 2022-08-03 18:52
Tx date 2018-08-16
$PHRX
Pharmadrug Inc.
Cohen, Daniel
5 - Senior Officer of Issuer
Holder: Daniel Cohen - RRSP (Indirect Ownership)
Common Shares
00 - Opening Balance-Initial SEDI Report
Filed 2022-08-03 18:50
Tx date 2022-08-02
$PHRX
Pharmadrug Inc.
Cohen, Daniel
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
16 - Acquisition or disposition under a prospectus exemption
$16,176
+323,525 vol
$0.05 each
3,019,570
Filed 2022-05-30 11:40
Tx date 2022-05-27
$PHRX
Pharmadrug Inc.
Cohen, Daniel
5 - Senior Officer of Issuer
Holder: 7725434 Canada Inc. (Indirect Ownership)
Warrants
16 - Acquisition or disposition under a prospectus exemption

+1,250,000 vol
1,871,500
Filed 2022-05-30 11:39
Tx date 2022-05-27
$PHRX
Pharmadrug Inc.
Cohen, Daniel
5 - Senior Officer of Issuer
Holder: 7725434 Canada Inc. (Indirect Ownership)
Common Shares
16 - Acquisition or disposition under a prospectus exemption
$50,000
+1,250,000 vol
$0.04 each
2,550,000
Filed 2022-05-27 14:30
Tx date 2020-07-17
$PHRX
Pharmadrug Inc.
Cohen, Daniel
5 - Senior Officer of Issuer
Holder: 7725434 Canada Inc. (Indirect Ownership)
Warrants
16 - Acquisition or disposition under a prospectus exemption

+621,500 vol
621,500
Filed 2022-05-27 14:25
Tx date 2021-09-24
$PHRX
Pharmadrug Inc.
Cohen, Daniel
5 - Senior Officer of Issuer
Direct Ownership
Options
52 - Expiration of options

-250,000 vol
3,750,000
Filed 2022-05-27 14:20
Tx date 2020-12-18
$PHRX
Pharmadrug Inc.
Cohen, Daniel
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
36 - Conversion or exchange

+2,696,045 vol
Filed 2020-12-18 17:18
Tx date 2020-12-18
$PHRX
Pharmadrug Inc.
Cohen, Daniel
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
36 - Conversion or exchange

+2,696,045 vol
Filed 2020-07-23 17:14
Tx date 2020-07-17
$PHRX
Pharmadrug Inc.
Cohen, Daniel
5 - Senior Officer of Issuer
Holder: 7725434 Canada Inc. (Indirect Ownership)
Warrants
16 - Acquisition or disposition under a prospectus exemption

+1,243,000 vol
Filed 2022-01-13 14:15
Tx date 2018-08-09
$PHRX
Pharmadrug Inc.
McClory, Paul Gerard Joseph
4 - Director of Issuer
Holder: Cayland Trust (Indirect Ownership)
Common Shares
00 - Opening Balance-Initial SEDI Report
300,000
Filed 2021-08-31 12:33
Tx date 2021-08-30
$PHRX
Pharmadrug Inc.
Kideckel, David
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options

+750,000 vol
750,000
Filed 2021-08-31 12:32
Tx date 2021-08-30
$PHRX
Pharmadrug Inc.
Kideckel, David
4 - Director of Issuer
Direct Ownership
Options
00 - Opening Balance-Initial SEDI Report
Filed 2021-08-31 12:32
Tx date 2021-08-30
$PHRX
Pharmadrug Inc.
Kideckel, David
4 - Director of Issuer
Direct Ownership
Common Shares
00 - Opening Balance-Initial SEDI Report